Companies offering Enbrel (etanercept)
Enbrel, whose active ingredient is etanercept, is a biologic drug that blocks tumor necrosis factor to treat autoimmune conditions such as rheumatoid arthritis, psoriatic arthritis, juvenile idiopathic arthritis, ankylosing spondylitis, and plaque psoriasis.
10
companies
List of companies that offer Enbrel (etanercept)
This is sourced from job postings — companies only hire for what they actively use or plan to adopt · how we source this →
| Company | Country | Industry | Employees | Revenue | Technologies |
|---|---|---|---|---|---|
United States | Biotechnology Research | 41k | $26B | Enbrel (etanercept) | |
United States | Pharmaceutical Manufacturing | 107k | $100B | Enbrel (etanercept) | |
United States | Hospitals and Health Care | 1k | $6.4M | Enbrel (etanercept) | |
United States | Hospitals and Health Care | 222 | $7M | Enbrel (etanercept) | |
United States | Hospitals and Health Care | 1.9k | Enbrel (etanercept) |
Showing top companies out of 10 that offer Enbrel (etanercept). Get the full list on TheirStack.
Frequently asked questions




